Transgene Biotek Other Announcement
Transgene Biotech appointed M/s. Harish Gummadi & Co as Statutory Auditor for a two-month term effective 2 November 2026. The appointment was approved at the board meeting on the same date.
- Execution
- 2 months
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Transgene Biotech appointed M/s. Harish Gummadi & Co as Statutory Auditor for a two-month term effective 2 November 2026. The appointment was approved at the board meeting on the same date.
The company filed a Regulation 74(5) certificate from its Registrar, confirming dematerialization activities for the quarter ended September 30, 2026.
Transgene Biotek submitted its quarterly shareholding pattern for the period ending December 2016. The company noted that certain promoter shares remain in physical form pending listing approval.